Hepatic and portal vein embolisation prior to major hepatectomy

Rochet E, Stringer D, Gassner L, Vandepeer M, Forel D, Bachlani A, Duncan J
Record ID 32018002665
English
Authors' objectives: This systematic review evaluates whether hepatic and portal vein embolisation is more effective and safer in comparison to portal vein embolisation for volume optimisation in patients prior to major hepatectomy.
Authors' results and conclusions: A total of three retrospective comparative studies and two prospective case series were included. Simultaneous hepatic and portal vein embolisation seems to be the preferred technique compared to sequential portal and hepatic vein embolisation, as the delay for surgery is reduced, and it can be performed as a dual procedure instead of two separate procedures. However, future liver remnant hypertrophy seems to be greater and faster with hepatic and portal vein embolisation than portal vein embolisation alone, whereas it did not appear to improve the unresectability due to disease progression or reduce the time between embolisation and resection. Hepatic and portal vein embolisation appears to be as safe as portal vein embolisation alone. No conclusion can be made whether hepatic and portal vein embolisation leads to better outcomes than the first-line comparator portal vein embolisation.
Authors' recommendations: A total of three retrospective comparative studies and two prospective case series were included. Simultaneous hepatic and portal vein embolisation seems to be the preferred technique compared to sequential portal and hepatic vein embolisation, as the delay for surgery is reduced, and it can be performed as a dual procedure instead of two separate procedures. However, future liver remnant hypertrophy seems to be greater and faster with hepatic and portal vein embolisation than portal vein embolisation alone, whereas it did not appear to improve the unresectability due to disease progression or reduce the time between embolisation and resection. Hepatic and portal vein embolisation appears to be as safe as portal vein embolisation alone. No conclusion can be made whether hepatic and portal vein embolisation leads to better outcomes than the first-line comparator portal vein embolisation.
Details
Project Status: Completed
Year Published: 2022
URL for additional information: https://eprints.aihta.at/1390
English language abstract: An English language summary is available
Publication Type: Full HTA
Country: Austria
MeSH Terms
  • Carcinoma, Hepatocellular
  • Hepatic Veins
  • Portal Vein
  • Embolization, Therapeutic
  • Hepatectomy
  • Liver Neoplasms
Keywords
  • Hepatic vein embolisation
  • portal vein embolisation
  • liver cancer
  • hepatectomy
Contact
Organisation Name: Austrian Institute for Health Technology Assessment
Contact Address: Garnisongasse 7/20, A-1090 Vienna, Austria
Contact Name: office@aihta.at
Contact Email: office@aihta.at
This is a bibliographic record of a published health technology assessment from a member of INAHTA or other HTA producer. No evaluation of the quality of this assessment has been made for the HTA database.